Related Experiment Video
Updated: Aug 20, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins
Kerstin Rabausch1, Ellen Bretschneider, Mario Sarbia
1Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum Düsseldorf, Germany.
Abstract:
There is concern that cyclooxygenase (COX)-2 inhibitors may promote atherothrombosis by inhibiting vascular formation of prostacyclin (PGI2) and an increased thrombotic risk of COX-2 inhibitors has been reported. It is widely accepted that the prothrombotic effects of COX-2 inhibitors can be explained by the removal of platelet-inhibitory PGI2. Using microarray chip technology, we have previously demonstrated that thrombomodulin (TM) mRNA is upregulated in cultured human coronary artery smooth muscle cells by the stable prostacyclin mimetic iloprost. This study is the first to demonstrate a stimulation of the expression of functionally active thrombomodulin in human smooth muscle cells by prostaglandins, endogenously formed via the COX-2 pathway. Because TM is an important inhibitor of blood coagulation, these findings provide a novel platelet-independent mechanism to explain the prothrombotic effects of COX-2 inhibitors. The full text of this article is available online at http://circres.ahajournals.org.
Insights
Cyclooxygenase-2 (COX-2) inhibitors may increase clot risk. This study reveals COX-2 pathway prostaglandins stimulate thrombomodulin, a key coagulation inhibitor, offering a new explanation for this risk.
Area of Science:
- Cardiovascular Biology
- Thrombosis Research
- Pharmacology
Background:
- Cyclooxygenase-2 (COX-2) inhibitors are associated with atherothrombosis.
- The prothrombotic risk of COX-2 inhibitors is often attributed to reduced prostacyclin (PGI2) production.
- Prostacyclin normally inhibits platelet aggregation.
Purpose of the Study:
- To investigate the effect of COX-2 pathway prostaglandins on thrombomodulin (TM) expression in human smooth muscle cells.
- To explore a potential platelet-independent mechanism for the prothrombotic effects of COX-2 inhibitors.
Main Methods:
- Utilized microarray chip technology to assess TM mRNA levels.
- Studied the expression of functionally active thrombomodulin in human coronary artery smooth muscle cells.
- Investigated the role of endogenously formed prostaglandins via the COX-2 pathway.
Main Results:
- Demonstrated that prostaglandins, generated through the COX-2 pathway, stimulate the expression of functionally active thrombomodulin in human smooth muscle cells.
- Confirmed previous findings of iloprost-induced upregulation of TM mRNA.
Conclusions:
- Findings suggest a novel, platelet-independent mechanism contributing to the prothrombotic effects of COX-2 inhibitors.
- Stimulation of thrombomodulin by COX-2 pathway prostaglandins may counteract their antithrombotic effects, explaining observed risks.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Vascular Spasm
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Clot Retraction and Fibrinolysis
Intracellular Signaling Affects Focal Adhesions
Some...

